All protocols
Growth Hormone

CJC-1295 (No DAC) + Ipamorelin Stack & Dosing

Updated 2mo ago 6 min read 334+ helpful Calculator
Validity Score

Validity Score

18 Speculative
Evidence 41
Community 35
Completeness 71
Actionability 80
Coverage 80
Penalty -34

This score combines formal evidence, page completeness, calculator readiness, and community convergence.

What it is

This stack combines CJC-1295 without DAC with ipamorelin. The two compounds act on different GH-axis pathways, but the combo itself does not have a clean human evidence base as a combined product.

Evidence boundary

Investigational. Evidence for the individual ingredients does not establish a validated stack protocol.

Trial evidence

  • PMID 42578445 — Peptide Supplements and Their Therapeutic Applications in Sports Medicine.
  • PMID 42160466 — Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications.
  • PMID 42123471 — Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives.

Preparation and measurement

Reconstitution: 10 mg vial + 2 mL BAC = 5 mg/mL.

Concentration matches.

Reference schedule

Reference schedule
PhaseDoseDraw / measureFrequencyWeekly total
Weeks 1–2 (titration)200 mcg4 U (0.04 mL)1–3× daily1.4 mg/week
Weeks 3–4300 mcg6 U (0.06 mL)1–3× daily2.1 mg/week
Weeks 5–6400 mcg8 U (0.08 mL)1–3× daily2.8 mg/week
Weeks 7–12 (target)550 mcg11 U (0.11 mL)1–3× daily3.85 mg/week

Weeks 1–2 (titration)

Dose
200 mcg
Draw / measure
4 U (0.04 mL)
Frequency
1–3× daily
Weekly total
1.4 mg/week

Weeks 3–4

Dose
300 mcg
Draw / measure
6 U (0.06 mL)
Frequency
1–3× daily
Weekly total
2.1 mg/week

Weeks 5–6

Dose
400 mcg
Draw / measure
8 U (0.08 mL)
Frequency
1–3× daily
Weekly total
2.8 mg/week

Weeks 7–12 (target)

Dose
550 mcg
Draw / measure
11 U (0.11 mL)
Frequency
1–3× daily
Weekly total
3.85 mg/week

Weekly totals apply only during the active phase.

Titration rules

  • Titration schedule (per peptide; doses are combined CJC-1295 + Ipamorelin in equal parts):
  • Weeks 1–2 (titration): 200 mcg per dose, 1–3× daily.
  • Weeks 3–4: 300 mcg per dose, 1–3× daily.
  • Weeks 5–6: 400 mcg per dose, 1–3× daily.
  • Weeks 7–12 (target): 550 mcg per dose, 1–3× daily (pre-bed mandatory; AM/pre-workout optional).
  • Cycle structure: 12–16 weeks continuous, then 4-week break. An alternative schedule runs 12 weeks on, 4 weeks off, repeat.
  • Timing: Pre-bed dose 30–60 min before sleep, fasted (no food/protein in last 2h). Pre-workout dose ~30 min before training, fasted.
  • Bloodwork cadence: IGF-1 every 8–12 weeks. An alternative schedule includes cortisol monitoring given ipamorelin’s near-zero (but non-zero) cortisol effect.

Cycle length and breaks

An alternative schedule runs 12 weeks on, 4 weeks off, repeat. Effects on body composition, sleep quality, and recovery accumulate gradually over 8–12 weeks.

What to monitor

  • Sleep and recovery
  • Hunger changes
  • Water retention
  • Injection-site reactions

Practical rules

  • If notes are being compared, keep the timing consistent.
  • Avoid eating right after dosing if that is part of the note set.
  • Keep sleep and training steady.
  • Rotate sites.
Was this protocol helpful?
Share via

Dosing references

Peptide dosage chart Peptide dose calculator Syringe mixability

Related protocols

CJC-1295 (DAC) Peptide Protocol & DosingSermorelin Peptide Protocol & DosingTesamorelin Peptide Protocol & DosingCJC-1295 (No DAC) + Ipamorelin Blend Protocol
Supply & lot verification Availability and batch-linked COA records for CJC-1295 (No DAC) + Ipamorelin Stack & Dosing are tracked with the current supplier listings. View availability & COA →

Dosing Calculator

10 mg + 2 mL BAC · blend · week 1 200 mcg
LIVE CALCULATIONvolume / concentration / draw
RP–CALC–01
DRAW AMOUNT4 units0.04 mL · U-100
Draw 4 units, equivalent to 0.04 milliliters.
Concentration5 mg/mL
Selected dose0.2 mg (200 mcg) = 4 units
Enter a desired amount in milligrams or micrograms.
05 Standard amounts
1–10 mg · 0.5 mg steps
06 Suggested doses Select a row
1 unit = 0.01 mL on a U-100 syringe. Values retain decimal precision; visual marks are not silently snapped.
07 cycle summary

Vials required for Cycle

Estimate how much material you need for a full cycle, including cycle length and the number of cycles you plan to run.

Cycle total —
Total required vials —
Total reconstitution —
Total BAC water —
08 projected levels

How the draws stack up

A first-order model of depot absorption and elimination, run on the draws and cadence above. Pick the half-life from whatever your own source documents — this page does not assume one per compound. A planning sketch — not a prediction for any compound or any individual.

Half-life

Modelled level across the cycle. Each spike is one draw.

Accumulation—steady state vs one draw
Peak-to-trough—inside one interval
Steady state—about 4 half-lives
Draws modelled—at this cadence
Vial yieldat the selected amount
Draws per vial—
Lasts—
Volume used—
Limiting factor—
Water matrixsame vial, same amount
WaterStrengthDraw
0.5 mL——
1 mL——
2 mL——
3 mL——
5 mL——

Research Protocols

Keep up to date with latest protocols, updates and offers

An occasional email when a new protocol lands or an existing one is revised. No more than once a month.